US Patent 8765462 IL-12 immunotherapy for cancer
Patent 8765462 was granted and assigned to University Health Network on July, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 26 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Christopher J. Paige0
Jeffrey A. Medin0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08765462 IL-12 immunotherapy for cancer US Patent 8765462 IL-12 immunotherapy for cancer
Infobox
Patent Number
087654620
Patent Number
87654620
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
087654620
Date of Patent
July 1, 2014
0Patent Application Number
125988990
Date Filed
May 5, 2008
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08765462 IL-12 immunotherapy for cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08765462
Date of patent
July 1, 2014
Patent application number
12598899
Date Filed
May 5, 2008
Patent primary examiner
Find more entities like US Patent 8765462 IL-12 immunotherapy for cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
